Multiple Indian companies have released their quarterly financial results for Q3 FY26, demonstrating compliance with regulatory disclosure requirements under SEBI guidelines. The financial disclosures cover various business sectors and provide comprehensive performance data for the quarter and nine months ended December 31, 2025.

Companies Reporting Financial Results

Several companies have submitted their unaudited standalone and consolidated financial results under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The reporting companies span different industry sectors, reflecting diverse business operations and financial performance metrics.

Regulatory Compliance Framework

The financial results have been prepared in accordance with Indian Accounting Standards (Ind AS) prescribed under Section 133 of the Companies Act, 2013. All companies have ensured compliance with the statutory requirements for quarterly financial disclosures, maintaining transparency in their financial reporting processes.

The results encompass both quarterly performance for Q3 FY26 and cumulative nine-month performance, providing stakeholders with comprehensive insights into operational efficiency and financial health across different reporting periods.

Board Approvals and Audit Processes

The financial results have received necessary approvals from respective Boards of Directors at meetings held in February 2026. The unaudited financial statements have undergone limited review processes by statutory auditors, ensuring adherence to accounting principles and regulatory standards.

These quarterly disclosures form part of the companies' ongoing commitment to maintaining transparency and providing regular updates to investors, regulators, and other stakeholders about their financial performance and business operations.

Market Disclosure Requirements

The complete financial results are available on stock exchange websites, including BSE Limited, providing public access to detailed financial information. Companies have fulfilled their obligations under SEBI regulations by ensuring timely submission and publication of their quarterly financial performance data.

The diverse range of reporting companies reflects the broad-based nature of corporate financial disclosures across different industry segments in the Indian market, demonstrating the comprehensive regulatory framework governing listed entities.

Triochem Products Limited has filed its quarterly Statement of Deviation or Variation in Public Issue with BSE Limited for the quarter ended December 31, 2025, in compliance with Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The submission was made on February 13, 2026, by Director Ramu S. Deora.

Regulatory Compliance Filing

The statement confirms that the company did not undertake any fund raising activities during the quarter ended December 31, 2025. The filing indicates that no public issues, rights issues, preferential issues, or other fund raising mechanisms were utilized by the company during this period.

Audit Committee and Auditor Comments

The Audit Committee provided specific comments regarding the filing, stating that "the statement of Category wise variation is also not applicable as there has been no offer made by way of Public Issue, Rights Issue, Preferential Issue, etc., during the Quarter ended 31st December 2025."

Similarly, the company's auditors confirmed the non-applicability of the statement, noting that "there is no offer made by way of Public Issue, Right Issue, Preferential Issue, etc."

Company Information

Triochem Products Limited operates from its registered office at 4th Floor, Sambava Chambers, Sir. P. M. Road, Fort, Mumbai, Maharashtra. The company trades on BSE with security code 512101 and ISIN number INE331E01013. The filing was signed by Ramu S. Deora, Director with DIN 00312369, ensuring proper authorization and compliance with regulatory requirements.

The submission follows the amended guidelines as per SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, demonstrating the company's commitment to maintaining transparency and regulatory compliance in its financial reporting obligations.